Quantitative Mass Spectrometry Normalization in Urine Biomarker Analysis in Nephrotic Syndrome

Chronic kidney disease (CKD) affects 30 million adults, costs ∼$79 billion dollars (2016) in Medicare expenditures, and is the ninth leading cause of death in the USA. The disease is silent or undiagnosed in almost half of people with severely reduced kidney function. The urine provides an ideal bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Cummins, Timothy D., Powell, David W., Wilkey, Daniel W., Brady, Makayla P., Benz, Fredrick W., Barati, Michelle T., Caster, Dawn J., Klein, Jon B., Merchant, Michael L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Methods Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529004/
https://www.ncbi.nlm.nih.gov/pubmed/36199623
http://dx.doi.org/10.1159/000522217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529004/
https://www.ncbi.nlm.nih.gov/pubmed/36199623
http://dx.doi.org/10.1159/000522217

Ejemplares similares